SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PASQUINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.780
AS - Asia 2.123
EU - Europa 948
SA - Sud America 446
AF - Africa 64
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.675
SG - Singapore 810
CN - Cina 416
BR - Brasile 365
IT - Italia 346
VN - Vietnam 282
HK - Hong Kong 179
DE - Germania 130
GB - Regno Unito 86
FR - Francia 84
TR - Turchia 67
IN - India 63
JP - Giappone 63
ID - Indonesia 60
CA - Canada 58
RU - Federazione Russa 53
FI - Finlandia 45
PL - Polonia 45
UA - Ucraina 36
BD - Bangladesh 35
AR - Argentina 32
MX - Messico 32
ZA - Sudafrica 24
NL - Olanda 23
SE - Svezia 19
TW - Taiwan 19
PK - Pakistan 18
IQ - Iraq 16
CH - Svizzera 15
ES - Italia 15
CO - Colombia 13
MA - Marocco 13
MY - Malesia 13
SA - Arabia Saudita 12
EC - Ecuador 11
AT - Austria 10
KE - Kenya 10
KR - Corea 9
UZ - Uzbekistan 9
AU - Australia 8
LT - Lituania 8
VE - Venezuela 8
BE - Belgio 7
TN - Tunisia 7
PH - Filippine 6
BH - Bahrain 5
IR - Iran 5
JO - Giordania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
IL - Israele 4
PT - Portogallo 4
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
UY - Uruguay 3
BO - Bolivia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
JM - Giamaica 2
KG - Kirghizistan 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
KH - Cambogia 1
MK - Macedonia 1
MM - Myanmar 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
Totale 6.370
Salva come PNG Salva come JPEG
Città #
Ashburn 513
Singapore 507
San Jose 214
Hong Kong 175
Fairfield 165
Beijing 156
Santa Clara 147
Council Bluffs 107
Woodbridge 107
Chandler 104
Ho Chi Minh City 96
Los Angeles 94
Houston 90
Ferrara 82
Seattle 73
Hanoi 65
Munich 61
Tokyo 59
Cambridge 55
Jakarta 53
New York 50
Lauterbourg 48
Wilmington 47
Dallas 43
Warsaw 41
Milan 39
Ann Arbor 37
São Paulo 37
Orem 33
Shanghai 33
Jacksonville 29
Izmir 28
Buffalo 27
Princeton 27
Bologna 26
Denver 25
Chennai 22
London 22
Chicago 19
Toronto 19
Turku 18
Frankfurt am Main 17
Mexico City 16
Montreal 16
Hefei 15
Helsinki 15
Rio de Janeiro 15
Zurich 15
Da Nang 14
Taipei 14
Manchester 13
Johannesburg 12
Poplar 12
Atlanta 11
Brooklyn 11
Haiphong 11
Nanjing 11
Nuremberg 11
San Francisco 11
Ankara 10
Boston 10
Phoenix 10
San Diego 10
Boardman 9
Falls Church 9
Kuala Lumpur 9
Moscow 9
Rome 9
Tucson 9
Venice 9
Vercelli 9
Ferrara di Monte Baldo 8
Florence 8
Istanbul 8
Nice 8
Tashkent 8
Belo Horizonte 7
Curitiba 7
Nairobi 7
Salt Lake City 7
Salvador 7
San Antonio 7
Stockholm 7
Baghdad 6
Biên Hòa 6
Brussels 6
Goiânia 6
Hải Dương 6
Nanchang 6
Ottawa 6
The Dalles 6
Verona 6
Blumenau 5
Bắc Ninh 5
Chattanooga 5
Columbus 5
Faisalabad 5
Genoa 5
Homburg 5
New Delhi 5
Totale 4.128
Salva come PNG Salva come JPEG
Nome #
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 270
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 257
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 251
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 239
The role of adenosinergic system in brain ischemia 234
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 200
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 196
Development of novel pyridazinone-based adenosine receptor ligands 181
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 175
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 170
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 165
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 162
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 152
Adenosine and inflammation: Here, there and everywhere 148
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 146
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 143
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 143
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 141
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 137
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 135
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease 131
Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta 131
Pharmacology of Adenosine Receptors: Recent Advancements 129
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes 128
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 123
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 123
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 122
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation 121
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 116
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 115
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications 115
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 114
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 113
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 111
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 109
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists 109
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy 105
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 104
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 104
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 98
Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents 97
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 96
Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation 96
Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain 91
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists 77
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy 40
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 33
Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo 15
Totale 6.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 58 39 10
2021/2022228 10 14 13 0 5 17 27 20 16 18 44 44
2022/2023286 29 48 4 27 23 20 43 22 24 9 23 14
2023/2024235 17 14 9 6 38 13 11 24 7 13 10 73
2024/20251.440 39 62 116 58 127 149 104 88 226 163 170 138
2025/20263.491 372 186 307 460 568 217 414 237 325 405 0 0
Totale 6.511